Atlas FDA

5F MYNXGRIP VASCULAR CLOSURE DEVICE (MX5021)

FDA premarket approval P040044/S064 · decided 2015-07-28

Approval details

PMA number
P040044
Supplement
S064
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
5F MYNXGRIP VASCULAR CLOSURE DEVICE (MX5021)
Generic name
Device, hemostasis, vascular
Applicant
Cordis US Corporation
Date received
2015-07-02
Decision date
2015-07-28
Days to decision
26 days
Decision code
OK30
Product code
MGB
Advisory committee
Cardiovascular
Expedited review
No
Location
Miami Lakes, FL
Statement
MODIFY THE HYDROGEL MANUFACTURING PROCESS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.